Posted : 5 December 2019
Treating Liver Diseases: Is this preclinical model the solution?
More details on LABIOTECH’s latest article
#humanliver #immune #Transcure #Labiotech #Humanizedmice #CRO #PreClinicalTrials
TransCure bioServices Overview (PDF, Q32018)
TransCure bioServices priority is the health of all our collaborators and the well-being of the animals under our supervision while also ensuring the continuity of our customer’s projects. At this point:
Implementation of COVID-19 Measures to reduce its impact on our Services
Our Executive Leadership Team is e-meeting frequently in order to evaluate the global and local situations and to ensure that we provide resources and information to manage the situation as effectively as possible. Here are some actions that TransCure bioServices are taking in order to mitigate the effects on our services and business to our customers:
For any questions or concerns, please contact us.
Please fill out the information below:
Number of CD34+ Humanised Mouse*
Request boosted Hu-Mice for: NK, APC?
Subscribe me your mailing list
Test de popup divi